Literature DB >> 21167146

¹H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure.

Seok-Min Kang1, Jong-Chul Park, Min-Jeong Shin, Hyeran Lee, Jaewon Oh, Do Hyun Ryu, Geum-Sook Hwang, Ji Hyung Chung.   

Abstract

OBJECTIVES: We sought to identify metabolic pathways characterizing human heart failure (HF) using ¹NMR based urinary metabolomic analysis in conjunction with multivariate statistics. DESIGN AND METHODS: Patients with systolic HF of ischemic origin (n=15) and healthy controls (n=20) participated in this study. Patients with type 2 diabetes mellitus were excluded.
RESULTS: The results showed that the urine of the HF patients had higher levels of metabolites for acetate (p<0.05) and acetone (p<0.01) compared to the healthy controls. In addition, there was a perturbation in methylmalonate metabolism as shown by increased urinary levels of methylmalonic acid (p<0.001) in the HF patients. HF patients also had increased urinary levels of cytosine (p<0.01) and phenylacetylglycine (p<0.01) and decreased 1-methylnicotinamide (p<0.05) compared to healthy controls.
CONCLUSIONS: TCA cycle metabolites and fatty acid metabolism were modified in the HF patients, indicating altered energy metabolism. Moreover, perturbations of metabolism in nucleotide and methylmalonate were observed.
Copyright © 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167146     DOI: 10.1016/j.clinbiochem.2010.11.010

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  28 in total

1.  Comparison of mouse urinary metabolic profiles after exposure to the inflammatory stressors γ radiation and lipopolysaccharide.

Authors:  Evagelia C Laiakis; Daniel R Hyduke; Albert J Fornace
Journal:  Radiat Res       Date:  2011-11-30       Impact factor: 2.841

2.  Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction.

Authors:  M Dan McKirnan; Yasuhiro Ichikawa; Zheng Zhang; Alice E Zemljic-Harpf; Sili Fan; Dinesh Kumar Barupal; Hemal H Patel; H Kirk Hammond; David M Roth
Journal:  Life Sci       Date:  2019-02-05       Impact factor: 5.037

3.  To ascertain the utility of urinary methyl malonic Acid as a potential marker of ischemic heart failure.

Authors:  Sonal Pruthi; Ankur Singh; Chandrawati Kumari; Ashish Goel; Seema Kapoor
Journal:  J Clin Diagn Res       Date:  2014-09-20

4.  Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure.

Authors:  Emirhan Nemutlu; Song Zhang; Yi-Zhou Xu; Andre Terzic; Li Zhong; Petras D Dzeja; Yong-Mei Cha
Journal:  J Card Fail       Date:  2015-04-22       Impact factor: 5.712

Review 5.  Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.

Authors:  Wynn G Hunter; Jacob P Kelly; Robert W McGarrah; William E Kraus; Svati H Shah
Journal:  Curr Heart Fail Rep       Date:  2016-06

6.  A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy.

Authors:  Weiguo Sui; Liping Li; Wenti Che; Zuo Guimai; Jiejing Chen; Wuxian Li; Yong Dai
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

7.  Metabolomic fingerprint of heart failure with preserved ejection fraction.

Authors:  Beshay N Zordoky; Miranda M Sung; Justin Ezekowitz; Rupasri Mandal; Beomsoo Han; Trent C Bjorndahl; Souhaila Bouatra; Todd Anderson; Gavin Y Oudit; David S Wishart; Jason R B Dyck
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

8.  Propionate-induced changes in cardiac metabolism, notably CoA trapping, are not altered by l-carnitine.

Authors:  Yingxue Wang; Bridgette A Christopher; Kirkland A Wilson; Deborah Muoio; Robert W McGarrah; Henri Brunengraber; Guo-Fang Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-07-17       Impact factor: 4.310

9.  Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.

Authors:  Clara Barrios; Michelle Beaumont; Tess Pallister; Judith Villar; Julia K Goodrich; Andrew Clark; Julio Pascual; Ruth E Ley; Tim D Spector; Jordana T Bell; Cristina Menni
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

10.  ProAlgaZyme subfraction improves the lipoprotein profile of hypercholesterolemic hamsters, while inhibiting production of betaine, carnitine, and choline metabolites.

Authors:  Andreea Geamanu; Arvind Goja; Nadia Saadat; Pramod Khosla; Smiti V Gupta
Journal:  Nutr Metab (Lond)       Date:  2013-08-27       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.